Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Go back to Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
(NASDAQ: AXSM) Delayed: 255.17 +1.40 (0.55%)
Previous Close $253.77    52 Week High $15.74 
Open $253.04    52 Week Low $5.37 
Day High $257.93    P/E N/A 
Day Low $253.04    EPS $0.00 
Volume 441,649